Physician
Williamson Memorial Hospital LLC
Williamson Memorial Hospital LLC was paid $3.66M by Medicaid between Jan 2018 and Apr 2020, across 110 billing codes. Its largest line is 74176, Computed tomography, abdomen and pelvis; without contrast material — 8.8% of everything it billed.
33Billing provider infoWILLIAMSON MEMORIAL HOSPITAL LLC
WILLIAMSON, WV 25661
WILLIAMSON, WV 25661
33aNPI1275528614assigned 09/13/2005
33bProvider typeFamily Medicine Physician
28Total paid$3.66M
24GClaims96,548
24DCodes billed110
24AFirst – last monthJan 2018 – Apr 2020
Compared with peers
Next to other Family Medicine Physician providers in West Virginia
Rank by total paid#13 of 202
Median peer was paid$172K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 55,635 | $2.18M | |
| 2019 | 33,822 | $1.19M | |
| 2020 | 7,091 | $292K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 8.8% | 1,201 | 889 | $323K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.9% | 1,890 | 1,373 | $291K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.6% | 3,559 | 2,707 | $278K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.3% | 4,084 | 3,214 | $193K |
| G0378 | Hospital observation service, per hour | 5.0% | 916 | 393 | $181K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.8% | 8,146 | 5,701 | $141K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.4% | 987 | 737 | $126K |
| 36415 | Collection of venous blood by venipuncture | 3.1% | 8,823 | 5,024 | $114K |
| 80053 | Comprehensive metabolic panel | 3.1% | 6,078 | 4,518 | $113K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.0% | 1,107 | 768 | $109K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.5% | 1,337 | 955 | $92K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.5% | 2,660 | 1,921 | $91K |
98 more codes
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2.3% | 1,392 | $83K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.9% | 1,241 | $69K |
| 84484 | 1.8% | 1,767 | $66K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 2,152 | $65K |
| 71045 | Radiologic examination, chest; single view | 1.8% | 1,953 | $65K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.6% | 1,640 | $58K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.4% | 2,450 | $50K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.3% | 155 | $49K |
| 81001 | 1.3% | 2,167 | $46K | |
| 94664 | 1.3% | 1,021 | $46K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 936 | $46K |
| J2550 | Injection, promethazine hcl, up to 50 mg | 1.2% | 768 | $43K |
| 83690 | 1.1% | 1,364 | $39K | |
| J2300 | Injection, nalbuphine hydrochloride, per 10 mg | 1.0% | 785 | $38K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,114 | $36K |
| 82150 | <1% | 913 | $35K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 273 | $35K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,687 | $34K |
| 80061 | Lipid panel | <1% | 1,450 | $30K |
| 87430 | <1% | 1,639 | $30K | |
| 87040 | <1% | 922 | $29K | |
| 86710 | <1% | 1,424 | $29K | |
| 86738 | <1% | 962 | $28K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 591 | $27K |
| 83880 | <1% | 648 | $25K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,275 | $25K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,408 | $24K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 608 | $24K |
| 87070 | <1% | 1,674 | $23K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,122 | $23K |
| 72131 | <1% | 282 | $23K | |
| 81003 | <1% | 908 | $20K | |
| 84703 | <1% | 981 | $17K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 701 | $16K |
| 82607 | <1% | 579 | $16K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 461 | $15K |
| 74018 | <1% | 106 | $14K | |
| 73630 | <1% | 339 | $13K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,072 | $13K |
| 36600 | <1% | 345 | $12K | |
| 85610 | <1% | 1,044 | $12K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,161 | $12K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 512 | $11K |
| 83735 | <1% | 619 | $11K | |
| 85730 | <1% | 524 | $10K | |
| 83605 | <1% | 487 | $10K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 299 | $9K |
| 82803 | <1% | 336 | $9K | |
| 73030 | <1% | 72 | $9K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 204 | $9K |
| 97035 | <1% | 287 | $8K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 241 | $7K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 314 | $7K |
| 87205 | <1% | 414 | $7K | |
| 87186 | <1% | 303 | $7K | |
| 82043 | <1% | 245 | $7K | |
| 85651 | <1% | 370 | $7K | |
| 82962 | <1% | 420 | $7K | |
| 73610 | <1% | 219 | $6K | |
| 82248 | <1% | 189 | $6K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 87 | $5K |
| 96376 | <1% | 182 | $5K | |
| 87088 | <1% | 122 | $5K | |
| 73562 | <1% | 165 | $5K | |
| 82652 | <1% | 104 | $4K | |
| 72100 | <1% | 65 | $4K | |
| 73130 | <1% | 89 | $4K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 414 | $4K |
| 85378 | <1% | 124 | $4K | |
| J3490 | Unclassified drugs | <1% | 308 | $3K |
| 70486 | <1% | 21 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 32 | $2K |
| 96367 | <1% | 57 | $2K | |
| 80076 | <1% | 178 | $2K | |
| 84439 | <1% | 85 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 125 | $1K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 14 | $1K |
| 84702 | <1% | 41 | $1K | |
| 80320 | <1% | 80 | $973.45 | |
| 82553 | <1% | 46 | $736.96 | |
| 80171 | <1% | 29 | $661.88 | |
| 81015 | <1% | 113 | $649.55 | |
| 84550 | <1% | 37 | $647.97 | |
| 86140 | <1% | 131 | $596.10 | |
| 82746 | <1% | 35 | $581.35 | |
| 85027 | <1% | 53 | $560.53 | |
| 86803 | <1% | 49 | $538.63 | |
| 87077 | <1% | 36 | $529.72 | |
| 94760 | <1% | 167 | $426.68 | |
| 99217 | <1% | 18 | $373.29 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 59 | $284.57 |
| 86430 | <1% | 38 | $195.69 | |
| 73590 | <1% | 19 | $160.31 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 38 | $130.18 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12 | $96.00 |
| 82550 | <1% | 18 | $61.85 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 22 | $60.87 |
| 90714 | <1% | 12 | $17.32 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRUNYON, SANDRA (PHYSICIAN PRACTICE MANAGER)